|
MPP6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.856999999994E-06 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
8.535800E-03 |
| Stage1-vs-Stage3 |
9.858000E-01 |
| Stage1-vs-Stage4 |
1.929640E-02 |
| Stage2-vs-Stage3 |
8.219100E-03 |
| Stage2-vs-Stage4 |
3.200000E-04 |
| Stage3-vs-Stage4 |
6.426000E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
3.69779762365852E-11 |
| Normal-vs-Asian |
<1E-12 |
| Caucasian-vs-AfricanAmerican |
9.535600E-01 |
| Caucasian-vs-Asian |
5.613800E-02 |
| AfricanAmerican-vs-Asian |
1.856010E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
5.510400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62558855265615E-12 |
| Normal-vs-Age(81-100Yrs) |
1.87486999999598E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.020000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.380810E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.388000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.739600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.765800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.663000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.197300E-03 |
| Classical-VS-Follicular |
6.345700E-02 |
| Classical-VS-Other |
8.612200E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
2.589200E-04 |
| Tall-VS-Other |
4.455400E-01 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
7.189800E-01 |
| Follicular-VS-Normal |
3.7979619449402E-12 |
| Other-VS-Normal |
2.040600E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11022302462516E-16 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
3.978100E-03 |
|
|
